The Digital Revolution: The Genesis of Patient-Driven Healthcare
Digital technology is reshaping the very contours of modern healthcare with the potential to sustainably transform the industry as we know it. The broad scope of digital health, as defined by the FDA, includes categories such as health information technology, telehealth, wearable devices, telemedicine and personalised medicine. By converging digital health and genomic technologies with […]
Problems with Today’s Cancer Drugs
Having the notorious status of being the ‘deadliest disease in the developed world’, cancer unscrupulously affects thousands of people across the globe each year. In 2021, it is estimated that cancer will be responsible for one in six deaths, making it the second most common cause of death globally (WHO, 2020). In Australia alone, it […]
Production underway on a new weapon to fight ovarian cancer
With one woman in Australia dying every eight hours from ovarian cancer, the urgency to address the unmet clinical need in cancer therapeutics has never been more paramount. A significant manufacturing agreement between OncoTEX Inc. (OncoTEX) and Sterling Pharma Solutions will see the production of novel platinum-resistant cancer-fighting drug, OxaliTEX, scaled up for preclinical and […]
GBS, Inc. receives approval to commence validation clinical study for rapid SARS-CoV-2 diagnostic test
NEW YORK APRIL 15, 2021 — GBS, Inc. (GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute) have received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a validation study to test clinical samples from […]
The iQ Group Global celebrates 10 years of innovation
Today marks a major milestone for The iQ Group Global with its 10th anniversary. What started as a bold vision to accelerate medical innovation by CEO and founder Dr George Syrmalis in 2011, has evolved into an internationally recognised bioscience investment consortium, championing a portfolio of world-first innovations in the fields of diagnostics and oncology. […]
How the pandemic could change the way we fight cancer
With all eyes on the global rollout of lifesaving COVID-19 vaccines, we now know how swiftly unmet clinical needs can be achieved when indomitable minds work collectively. In January 2020, experts began analysing the novel SARS-CoV-2 virus spreading through the human populous after researchers in China uploaded gene sequencing data to a public portal. In […]
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
New York, NY, February 18, 2021 – GBS Inc. (Nasdaq: GBS), a life sciences company that develops non-invasive, real-time point of care (POC) diagnostic tests for patients and their primary health practitioners, today announced the execution of a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate development of next-generation saliva-based diagnostic tests. […]
Harvard’s Wyss Institute collaborates with GBS Inc. on the Wyss’ eRapid-based COVID-19 diagnostic to help curb the pandemic
Combination of the Wyss’ electrochemical sensing technology with GBS’s transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in point-of-care applications. This article has been republished with permission from the Wyss Institute at Harvard University. Click here to view the original article. By Benjamin Boettner (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard […]
The iQ Group Global raises more than $1 million for cancer research
Vital research into children’s cancer has been bolstered through generous donations at the 2020 Tour de Cure Spring Lunch, with more than $1 million raised. Sponsored by presenting partner The iQ Group Global, the annual event received a raft of donations and support, with performances by Delta Goodrem, Matthew Copley and Prinnie Stevens. Channel Seven’s […]